Last Price$302.80.6%
Market Cap$17.3B
LTM Capital Expenditure
($100.0M)
YoY Growth
+19.0%
3Y CAGR
+9.1%
5Y CAGR
+11.9%
Stock quality & Intrinsic value
6/10
37.0% undervalued
Molina Healthcare, Inc. Capital Expenditure
Annual
Quarterly
LTM
Crunching data... Almost there!
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | ($14.0M) | ($20.3M) | ($22.3M) | ($34.7M) | ($35.9M) | ($48.5M) | ($60.6M) | ($78.1M) | ($98.0M) | ($114.9M) | ($132.0M) | ($176.0M) | ($86.0M) | ($30.0M) | ($57.0M) | ($74.0M) | ($77.0M) | ($91.0M) | ($84.0M) | ($100.0M) |
Overvalued or undervalued?
Check the intrinsic value for MOH
and see if it's the right time to invest.
Molina Healthcare, Inc. (MOH) Capital Expenditure comparison analysis
General
LTM Capital Expenditure
Growth
Company name
YoY growth
3Y CAGR
5Y CAGR
Molina Healthcare, Inc.MOH
($100.0M)
19.0%
9.1%
11.9%
Median Peer Set
($609.5M)
(5.7%)
4.1%
1.3%
Clover Health Investments, Corp.CLOV
($1,241.0K)
112.5%
19.7%
122.0%
Bright Health Group, Inc.BHG
($2,626.0K)
(90.4%)
(26.0%)
N/A
Oscar Health, Inc.OSCR
($27.9M)
9.1%
2.5%
N/A
Alignment Healthcare, Inc.ALHC
($41.4M)
15.1%
31.2%
N/A
Humana Inc.HUM
($575.0M)
(42.7%)
(24.1%)
(4.8%)
Centene CorporationCNC
($644.0M)
(19.4%)
(10.9%)
(2.5%)
Elevance Health Inc.ELV
($1,256.0M)
(3.1%)
4.9%
3.1%
Cigna CorporationCI
($1,406.0M)
(10.6%)
6.8%
6.0%
CVS Health CorporationCVS
($2,781.0M)
(8.2%)
3.3%
2.5%
UnitedHealth Group IncorporatedUNH
($3,499.0M)
3.3%
12.6%
11.1%
MOH key stats
USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
| Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
% growth | 1,650.1 40.4% | 2,005.0 21.5% | 2,492.5 24.3% | 3,112.4 24.9% | 3,669.4 17.9% | 4,086.0 11.4% | 4,769.9 16.7% | 6,028.8 26.4% | 6,588.9 9.3% | 9,666.6 46.7% | 14,072.0 45.6% | 17,711.0 25.9% | 19,883.0 12.3% | 18,890.0 (5.0%) | 16,829.0 (10.9%) | 19,423.0 15.4% | 27,771.0 43.0% | 31,974.0 15.1% | 34,072.0 6.6% | 40,650.0 19.3% |
| Cost of Goods Sold (COGS) | 1,424.9 | 1,678.7 | 2,080.1 | 2,621.3 | 3,176.2 | 3,449.5 | 4,004.0 | 5,397.0 | 5,713.6 | 8,616.1 | 12,434.0 | 15,941.0 | 18,003.0 | 16,266.0 | 14,394.0 | 16,746.0 | 24,491.0 | 28,048.0 | 29,738.0 | 0.0 |
% margin | 225.2 13.6% | 326.3 16.3% | 412.4 16.5% | 491.1 15.8% | 493.1 13.4% | 636.5 15.6% | 766.0 16.1% | 631.8 10.5% | 875.3 13.3% | 1,050.5 10.9% | 1,638.0 11.6% | 1,770.0 10.0% | 1,880.0 9.5% | 2,624.0 13.9% | 2,435.0 14.5% | 2,677.0 13.8% | 3,280.0 11.8% | 3,926.0 12.3% | 4,334.0 12.7% | 40,650.0 100.0% |
| Operating Expenses | 179.4 | 250.5 | 314.0 | 378.4 | 437.3 | 531.5 | 621.2 | 596.3 | 738.7 | 857.6 | 1,251.0 | 1,532.0 | 1,731.0 | 1,432.0 | 1,385.0 | 1,599.0 | 2,260.0 | 2,545.0 | 2,761.0 | 38,943.0 |
| Research & Development Expenses (R&D) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Selling, General & Administrative Expenses (SG&A) | 163.3 | 229.1 | 285.3 | 344.8 | 399.1 | 346.0 | 415.9 | 532.6 | 666.0 | 764.7 | 1,147.0 | 1,393.0 | 1,594.0 | 1,333.0 | 1,296.0 | 1,480.0 | 2,068.0 | 2,311.0 | 2,462.0 | 2,743.0 |
% margin | 45.8 2.8% | 75.8 3.8% | 98.3 3.9% | 112.6 3.6% | 57.4 1.6% | 105.0 2.6% | 80.2 1.7% | 35.5 0.6% | 136.6 2.1% | 192.9 2.0% | 387.0 2.8% | 238.0 1.3% | (555.0) (2.8%) | 1,131.0 6.0% | 1,044.0 6.2% | 1,078.0 5.6% | 1,020.0 3.7% | 1,173.0 3.7% | 1,573.0 4.6% | 1,707.0 4.2% |
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 87.0 | 102.0 | 120.0 | 110.0 | 0.0 | 0.0 |
| Interest Expense | 0.0 | 0.0 | 4.6 | 8.7 | 13.8 | 15.5 | 15.5 | 16.8 | 52.1 | 56.8 | 67.0 | 101.0 | 118.0 | 115.0 | 87.0 | 102.0 | 120.0 | 110.0 | 109.0 | 118.0 |
| Pre-tax Income | 43.9 | 73.5 | 93.7 | 103.9 | 43.6 | 89.5 | 64.7 | 19.1 | 81.1 | 135.3 | 322.0 | 137.0 | (612.0) | 999.0 | 972.0 | 961.0 | 875.0 | 1,063.0 | 1,464.0 | 1,589.0 |
% effective tax rate | 16.3 37.1% | 27.7 37.8% | 35.4 37.7% | 41.5 39.9% | 12.7 29.2% | 34.5 38.6% | 43.8 67.8% | 9.3 48.6% | 36.3 44.8% | 72.7 53.8% | 179.0 55.6% | 129.0 94.2% | (100.0) 16.3% | 292.0 29.2% | 235.0 24.2% | 288.0 30.0% | 216.0 24.7% | 271.0 25.5% | 373.0 25.5% | 410.0 25.8% |
% margin | 27.6 1.7% | 45.7 2.3% | 58.3 2.3% | 62.4 2.0% | 30.9 0.8% | 55.0 1.3% | 20.8 0.4% | 9.8 0.2% | 52.9 0.8% | 62.2 0.6% | 143.0 1.0% | 8.0 0.0% | (512.0) (2.6%) | 707.0 3.7% | 737.0 4.4% | 673.0 3.5% | 659.0 2.4% | 792.0 2.5% | 1,091.0 3.2% | 1,179.0 2.9% |
| EPS | 0.67 | 1.09 | 1.37 | 1.50 | 0.79 | 1.34 | 0.45 | 0.21 | 1.16 | 1.33 | 2.75 | 0.93 | (9.14) | 10.61 | 11.85 | 11.41 | 11.40 | 13.70 | 18.71 | 20.43 |
| Diluted EPS | 0.65 | 1.08 | 1.37 | 1.50 | 0.79 | 1.32 | 0.45 | 0.21 | 1.13 | 1.29 | 2.58 | 0.92 | (9.14) | 10.55 | 11.48 | 11.24 | 11.25 | 13.54 | 18.78 | 20.43 |
% margin | 60.9 3.7% | 97.3 4.9% | 126.3 5.1% | 146.3 4.7% | 94.0 2.6% | 165.8 4.1% | 210.2 4.4% | 118.3 2.0% | 214.1 3.2% | 332.7 3.4% | 514.0 3.7% | 488.0 2.8% | (316.0) (1.6%) | 1,241.0 6.6% | 1,148.0 6.8% | 1,151.0 5.9% | 1,126.0 4.1% | 1,349.0 4.2% | 1,744.0 5.1% | 1,893.0 4.7% |
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.
3M Return 35.3%
S&P Outperformance 22.3%
Next 3M Predicted Return 26.8%
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.
3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%
FAQ
1) What is Molina Healthcare, Inc.'s Capital Expenditure?
As of today, Molina Healthcare, Inc.'s last 12-month Capital Expenditure is ($100.0M), based on the financial report for Dec 31, 2024 (Q4’2024).
2) What is Molina Healthcare, Inc.'s Capital Expenditure growth rate?
Over the last year, Molina Healthcare, Inc.'s Capital Expenditure growth was 19.0%. The average annual Capital Expenditure growth rates for Molina Healthcare, Inc. have been 19.9% over the past three years, 11.9% over the past five years.
3) Is Molina Healthcare, Inc.'s Capital Expenditure growth rate Good?
Over the last year, Molina Healthcare, Inc.'s Capital Expenditure growth was 19.0%, which is higher than industry growth of (0.2%). It indicates that Molina Healthcare, Inc.'s Capital Expenditure growth is Bad.